HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Successful treatment of fetal hemolytic disease due to glucose phosphate isomerase deficiency (GPI) using repeated intrauterine transfusions: a case report.

Abstract
Hemolytic anemia due to GPI deficiency can be severe and life threatening during fetal life. When parents decline invasive testing, ultrasound monitoring of fetuses at risk is feasible. Intrauterine transfusion can be effective for the treatment of severe fetal anemia due to GPI deficiency.
AuthorsPhebe N Adama van Scheltema, Ai Zhang, Lynne M Ball, Sylke J Steggerda, Richard van Wijk, Dietje E Fransen van de Putte, Inge L van Kamp
JournalClinical case reports (Clin Case Rep) Vol. 3 Issue 10 Pg. 862-5 (Oct 2015) ISSN: 2050-0904 [Print] England
PMID26509025 (Publication Type: Case Reports)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: